- Male
- 32 Years
- 05/09/2025
My blood report shows a Mantoux test result with an induration of 22 mm, which is positive. What does this indicate?
Answered by 1 Apollo Doctors
22 mm is strongly positive and suggests TB exposure. A doctor may advise chest Xray or further TB tests depending on symptoms.
Dr. Hema Suggests...
Take a TB Gold Test Test
Answered 05/09/2025
0
1
More TB (QUANTIFERON) GAMMA INTERFERON (IGRA) Health Queries
View allHi, I have been taking tuberculosis medication for 8 months. My recent tests show that I no longer have tuberculosis. However, I have been experiencing a low grade fever of 99 to 99.3F for some time, and today it rose to 101F. Could you please explain the possible causes of this persistent fever and why it might be happening?
read more![Doctor 1]()
![Doctor 2]()
Answered by Apollo Doctors
Hello doctor, my Mantoux test was done two days ago. I attached pictures. Can you please tell me if it is positive or negative? Today the pathology lab where my test was done is closed for 2 days, so please help me. My past history: I was diagnosed with tuberculosis 2 years ago and completed my full course. After doctor consultation, medicine was stopped after 1 year. Again, due to pain in my full body, my physician advised this test. Can you please tell me the result?
read more![Doctor 1]()
![Doctor 2]()
Answered by Apollo Doctors
I am a 23 year old girl suffering from XDR lymphatic tuberculosis and I have been on medication for the last 13 months. The medicines are moxifloxacin, clofazimine, delamanid, bedaquiline and cycloserine. I took capreomycin injection for 8 months. My reports are negative now but I am suffering from body ache, weakness in legs and hands, and breathlessness. My period is due in the next 3 to 4 days. Why is this happening and what should I do?
read more![Doctor 1]()
![Doctor 2]()
Answered by Apollo Doctors
Disclaimer: Answers on Apollo 247 are not intended to replace your doctor advice. Always seek help of a professional doctor in case of an medical emergency or ailment.
